176 related articles for article (PubMed ID: 32533977)
1. Pharmacodynamics and pharmacokinetics of the novel synthetic opioid, U-47700, in male rats.
Truver MT; Smith CR; Garibay N; Kopajtic TA; Swortwood MJ; Baumann MH
Neuropharmacology; 2020 Oct; 177():108195. PubMed ID: 32533977
[TBL] [Abstract][Full Text] [Related]
2. Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats.
Walton SE; Krotulski AJ; Glatfelter GC; Walther D; Logan BK; Baumann MH
Psychopharmacology (Berl); 2023 Jan; 240(1):185-198. PubMed ID: 36526866
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats.
Bergh MS; Bogen IL; Garibay N; Baumann MH
Psychopharmacology (Berl); 2021 Dec; 238(12):3629-3641. PubMed ID: 34613431
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.
Baumann MH; Majumdar S; Le Rouzic V; Hunkele A; Uprety R; Huang XP; Xu J; Roth BL; Pan YX; Pasternak GW
Neuropharmacology; 2018 May; 134(Pt A):101-107. PubMed ID: 28807672
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats.
Carlier J; Wohlfarth A; Salmeron BD; Scheidweiler KB; Huestis MA; Baumann MH
J Pharmacol Exp Ther; 2018 Dec; 367(3):543-550. PubMed ID: 30266766
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.
Krotulski AJ; Garibay N; Walther D; Walton SE; Mohr ALA; Logan BK; Baumann MH
Neuropharmacology; 2021 Nov; 199():108800. PubMed ID: 34547333
[TBL] [Abstract][Full Text] [Related]
7. Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats.
Bergh MS; Bogen IL; Garibay N; Baumann MH
Neuropharmacology; 2019 Nov; 158():107596. PubMed ID: 30965021
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework.
Mohr AL; Friscia M; Papsun D; Kacinko SL; Buzby D; Logan BK
J Anal Toxicol; 2016 Nov; 40(9):709-717. PubMed ID: 27590036
[TBL] [Abstract][Full Text] [Related]
9. Quantification of U-47700 and its metabolites in plasma by LC-MS/MS.
Smith CR; Truver MT; Swortwood MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():41-47. PubMed ID: 30849683
[TBL] [Abstract][Full Text] [Related]
10. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
[TBL] [Abstract][Full Text] [Related]
12. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
13. U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market.
Baumann MH; Tocco G; Papsun DM; Mohr AL; Fogarty MF; Krotulski AJ
Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33238449
[TBL] [Abstract][Full Text] [Related]
14. Brain disposition, metabolism and behavioral effects of the synthetic opioid AH-7921 in rats.
Lucchetti J; Marzo CM; Passoni A; Moro F; di Clemente A; Bagnati R; Cervo L; Gobbi M
Neuropharmacology; 2018 May; 133():51-62. PubMed ID: 29366664
[TBL] [Abstract][Full Text] [Related]
15. A case of U-47700 overdose with laboratory confirmation and metabolite identification.
Jones MJ; Hernandez BS; Janis GC; Stellpflug SJ
Clin Toxicol (Phila); 2017 Jan; 55(1):55-59. PubMed ID: 27549165
[TBL] [Abstract][Full Text] [Related]
16. Long-term stability of novel synthetic opioids in blood.
Truver MT; Swortwood-Gates MJ
Forensic Sci Int; 2020 Mar; 308():110175. PubMed ID: 32032869
[TBL] [Abstract][Full Text] [Related]
17. Ultralow dose fentanyl prevents development of chronic neuropathic pain in rats.
Wala EP; Holtman JR; Sloan PA
J Opioid Manag; 2013; 9(2):85-96. PubMed ID: 23709318
[TBL] [Abstract][Full Text] [Related]
18. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
19. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats.
Cabral AM; Varner KJ; Kapusta DR
J Pharmacol Exp Ther; 1997 Aug; 282(2):609-16. PubMed ID: 9262322
[TBL] [Abstract][Full Text] [Related]
20. An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
Chen XH; Adams JU; Geller EB; DeRiel JK; Adler MW; Liu-Chen LY
Eur J Pharmacol; 1995 Feb; 275(1):105-8. PubMed ID: 7774656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
